Cover Image
Market Research Report

Sepsis - Diagnosis Report

Published by Boston Strategic Partners, Inc. Product code 557097
Published Content info 55 Pages
Delivery time: 1-2 business days
Price
Back to Top
Sepsis - Diagnosis Report
Published: July 31, 2017 Content info: 55 Pages
Description

In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. Informed by real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals across the US, Boston Strategic Partners (BSP) Real World data report, Hospital-Treated Sepsis: Diagnosis, estimates 30% of all hospital discharges involve treatment of infectious organisms. Sepsis is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, costs, and laboratory testing.

Hospital-Treated Sepsis: Diagnosis

Gram-positive bacteria are the likely causative agents of most sepsis infections. From 2010-2015, drug resistant organisms caused an astonishing 40% of bacterial sepsis infections. Hospital-Treated Sepsis: Diagnosis is part one of a two-part series on hospital-treated sepsis. This report provides quantitative, objective data focused on the diagnosis of sepsis requiring hospitalization. The data provides real-world patient encounters and reflects real physician diagnostic decisions and encounter characteristics (e.g. admissions and lab testing) in key areas, such as antibiotic resistant pathogens.

Table of Contents

Table of Contents

1. Outline

2. Executive Summary

3. Incidence and Impact of Disease

  • a. Incidence
  • b. Length of Stay
  • c. Total Cost

4. Patient Demographics

  • a. Age
  • b. Insurance type
  • c. Gender
  • d. Region
  • e. Mortality
  • f. Comorbid Conditions

5. Patient Segmentation by Diagnostic Testing

  • a. Causative Etiologic Agent

6. Length of Stay and Cost by Patient Segment

  • a. Age at Admission
  • b. APACHE II Score
  • c. First Care Setting

7. Patient Flow through the Hospital

  • a. Admission Site
  • b. Lab Testing
  • c. Lab TAT
  • d. Results
  • e. Etiology

8. Drug Resistant Sepsis

  • a. Current Trends
  • b. Costs
  • c. Comorbidity
  • d. LOS
  • e. Mortality

9. Database Overview

10. Methodology

Back to Top